Science & Technology
Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R44TR004975-02A1
Award Ceiling
$1.1M
Award Floor
$1.1M
Close Date
Aug 31, 2027
534 days leftTotal Funding
$1.1M
Expected Awards
1
Posted Date
Sep 25, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2R44TR004975-02A1
Description
SBIR Phase Phase II award: "Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing" awarded to Syntr Health Technologies, Inc in Irvine, California. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,050,276. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, HUBZone businesses, Socially/economically disadvantaged
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.